Profilaktik Mastektomide Meme Rekonstrüksiyonu
Abstract
Keywords
Breast cancer, BRCA 1-2, Prophylactic, Mastectomy, Breast reconstruction, Implant, Autologous.
References
- 1. Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer statistics. CA: A Cancer Journal for Clinicians 2001; 51: 15–36.
- 2. Van Sprundel TC, Schmidt MK, Rookus MA, et al. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA 2 mutation carriers. Br J Cancer. 2005; 93: 287-292.
- 3. McDonnell SK, Schaid DJ, Myers JL, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001; 19: 3938-3943.
- 4. Penisi, V.R., Capozzi, A. Subcutaneous mastectomy data: Final statistical analysis. Aesth Plast Surg 1989; 13: 15
- 5.American Cancer Society. Breast Cancer Facts & Figures 2009-2010. Atlanta: American Cancer Society, Inc.
- 6. McPherson, K., Steel, G.M., Dixon, J.M. ABC of breast diseases: Breast cancer- Epidemiology, risk factors, and genetics. B.M.J. 2000; 321: 624.
- 7. Armstrong, K., Eisen, A., Weber, B. Assessing the risk of breast cancer. N Engl.J.Med 2000; 342: 564.
- 8. Carlson GW. Skin sparing mastectomy: anatomic and technical considerations. Am Surg 1996; 62: 151-155.
- 9. Shrotria S. The peri-areolar incision— gateway to the breast Eur J Surg Oncol 2001; 27: 601–603.
- 10. Singletary SE, Robb GL. Oncologic safety of skin-sparing mastectomy. Ann Surg Oncol 2003; 10: 95-97.